바이오톡스텍
2,030KRWMarket close of 10/20 (Tue)
Up +0.25%+5KRWMarket close of 10/20 (Tue)
- Open
- 2,025
- High
- 2,040
- Low
- 2,000
- Day range
- Day range low 2,000 high 2,040, open 2,025, close 2,030, previous close 2,025
- Volume
- 0×10K shares
- 10.04 million KRW 0.49× the 20-session average
Market close of 10/20 (Tue)
Where it sits in the 1-year range
2%1-year close range 1,983 to 3,925 won, 2% up from the low
2% of the way up from the lowest close in 1 year (252 sessions) · -48.3% from the high
Something to check
1 to check: operating loss
Free · no sign-inSource from 2021-05-17
Points to check
- Earningsto check-5.2B KRWOperating income over the last four quarters -5.2B KRW (loss)
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
The other 3 are within the usual range
- Daily move+0.25%usual range
- Trading value0.5×usual range
- Data date10/20 (Tue)Market close
See the full check report
Quarterly results · Q1 2026
- Revenue11.9B KRW
- vs. year ago
- +5.5%
- vs. prior quarter
- -16.7%
- Operating income-1.8B KRW
- vs. year ago
- Still a loss
- vs. prior quarter
- Still a loss
- Operating margin-15.4%
- vs. year ago
- -2.7 pp
- vs. prior quarter
- -14.7 pp
Quarterly operating income trend
As of the latest official close · 2026-10-20Valuation filing date · 2026-05-15Same sector · 바이오 R&D
Down -2.19%· 16 of 64 stocks up, preferred shares excluded · trading value 190.5B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 알테오젠 | Close over the last 20 sessions -9.6% | Down -3.35% | 51.1B KRW |
| 올릭스 | Close over the last 20 sessions -12.2% | Down -4.03% | 19.1B KRW |
| 디앤디파마텍 | Close over the last 20 sessions -11.8% | Down -1.93% | 15.1B KRW |
| 리가켐바이오 | Close over the last 20 sessions -15.4% | Down -1.41% | 12.1B KRW |
| 프로티나 | Close over the last 20 sessions +31.8% | Up +7.38% | 10.0B KRW |
Schedule
- Next data 10/22 (Thu) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.